ATE213334T1 - Vorgeburtliche überprüfung von schwangerschaftsabnormitäten - Google Patents

Vorgeburtliche überprüfung von schwangerschaftsabnormitäten

Info

Publication number
ATE213334T1
ATE213334T1 AT95305618T AT95305618T ATE213334T1 AT E213334 T1 ATE213334 T1 AT E213334T1 AT 95305618 T AT95305618 T AT 95305618T AT 95305618 T AT95305618 T AT 95305618T AT E213334 T1 ATE213334 T1 AT E213334T1
Authority
AT
Austria
Prior art keywords
marker
level
pregnancy
woman
abnormities
Prior art date
Application number
AT95305618T
Other languages
English (en)
Inventor
Andrew Jonathan Beard
Adrian Charles Dawkes
Christopher John Davies
Original Assignee
Johnson & Johnson Clin Diag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Clin Diag filed Critical Johnson & Johnson Clin Diag
Application granted granted Critical
Publication of ATE213334T1 publication Critical patent/ATE213334T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Data Mining & Analysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Databases & Information Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Fire Alarms (AREA)
AT95305618T 1994-08-13 1995-08-11 Vorgeburtliche überprüfung von schwangerschaftsabnormitäten ATE213334T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9416415A GB9416415D0 (en) 1994-08-13 1994-08-13 Antenatel screening for pregnacy abnormalities

Publications (1)

Publication Number Publication Date
ATE213334T1 true ATE213334T1 (de) 2002-02-15

Family

ID=10759858

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95305618T ATE213334T1 (de) 1994-08-13 1995-08-11 Vorgeburtliche überprüfung von schwangerschaftsabnormitäten

Country Status (10)

Country Link
US (1) US6022695A (de)
EP (1) EP0701131B1 (de)
JP (1) JP3626251B2 (de)
KR (1) KR100389988B1 (de)
AT (1) ATE213334T1 (de)
AU (1) AU698204B2 (de)
CA (1) CA2155919C (de)
DE (1) DE69525400T2 (de)
FI (1) FI119451B (de)
GB (1) GB9416415D0 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
GB9614615D0 (en) * 1996-07-11 1996-09-04 Isis Innovation Diagnosis of pre-eclampsia
US20050131738A1 (en) * 2002-05-15 2005-06-16 Morris Tommy J. System and method for handling medical information
CA2486089C (en) 2002-05-15 2013-12-17 Tommy J. Morris System and method for handling medical information
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
BRPI0417217A (pt) * 2003-12-02 2007-03-13 Shraga Rottem inteligência artificial e dispositivo para diagnóstico, seleção, prevenção e tratamento de condições materno-fetais
EP1716419A2 (de) * 2004-02-20 2006-11-02 AplaGen GmbH Verfahren zum nachweis von autoantikörpern gegen spezifische peptide und dessen verwendung bei der diagnose und behandlung von schwangerschaftsverlust oder unfruchtbarkeit
JP2010531991A (ja) * 2007-07-02 2010-09-30 ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラ 異所性妊娠の同定
US20100027571A1 (en) * 2008-07-31 2010-02-04 Murdoch Keith M Stabilized near-infrared laser
WO2011144999A1 (en) 2010-05-17 2011-11-24 Sandra Reznik Plasma protein-a2 (papp-a2) as a marker for detecting risk of chromosomal abnormalities
CN116358954B (zh) * 2023-02-22 2024-08-09 深圳市昭蓝生物科技有限公司 复合质控品及其制备方法和产前筛查试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
JP2525474B2 (ja) * 1987-07-09 1996-08-21 ３アイ・リサーチ・エクスプロイテーション・リミテッド 胎児のダウン症候群を検出する方法およびその装置
GB8816714D0 (en) * 1988-07-14 1988-08-17 Univ Court Of University Of Gl Switched reluctance motors
WO1990008325A1 (en) * 1989-01-17 1990-07-26 Macri James N Down syndrome screening method
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9410345D0 (en) * 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
US5716853A (en) * 1995-07-07 1998-02-10 Chiron Diagnostics Corporation Prenatal down syndrome screening with assays specific for UGP

Also Published As

Publication number Publication date
JPH09113508A (ja) 1997-05-02
FI119451B (fi) 2008-11-14
AU2848795A (en) 1996-02-29
EP0701131B1 (de) 2002-02-13
FI953830L (fi) 1996-02-14
US6022695A (en) 2000-02-08
CA2155919C (en) 2007-06-05
FI953830A0 (fi) 1995-08-11
GB9416415D0 (en) 1994-10-05
JP3626251B2 (ja) 2005-03-02
KR960008312A (ko) 1996-03-22
EP0701131A2 (de) 1996-03-13
DE69525400D1 (de) 2002-03-21
DE69525400T2 (de) 2002-07-18
CA2155919A1 (en) 1996-02-14
EP0701131A3 (de) 1996-05-29
KR100389988B1 (ko) 2003-12-06
AU698204B2 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
DE69525400D1 (de) Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten
ES2262319T3 (es) Cribado prenatal para sindrome de down.
Haddow et al. Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester.
DE69328169D1 (de) Prüfung vor der geburt für abnormitäten der chromosomen
CA2121680A1 (en) Screening method for identifying women at increased risk for preterm delivery
DE69739072D1 (de) Pränatales down-syndrom-testverfahren unter benutzung von hyperglykosyliertem gonadotropin
ATE227024T1 (de) Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut
DE3882140D1 (en) Praenatales screening fuer downs-syndrom.
Zeitune et al. Estimating the risk of a fetal autosomal trisomy at mid‐trimester using maternal serum alpha fetoprotein and age: A retrospective study of 142 pregnancies
SMITH et al. Interpretation of in‐vitro thyroid function tests during pregnancy
DE69418759D1 (de) Vorgeburtliche Überprüfung von Missbildungen der Chromosomen
Loncar et al. Advent of maternal serum markers for Down syndrome screening
Canini et al. Comparison of First Trimester, Second Trimester and Integrated Downs Syndrome Screening Results in Unaffected Pregnancies
DE69418654D1 (de) Vorgeburtliche Überprüfung von Missbildungen der Chromosomen
ATE240525T1 (de) Pränatales testverfahren für down-syndrom
James et al. Is the lecithin/sphingomyelin ratio outdated?
Easterling et al. Maternal weight, hemodynamics, and preeclampsia
Petrikovsky Procedural risks versus theology: Chorionic villus sampling for Orthodox Jews at less than 8 weeks' gestation
Chodirker Maternal serum screening: What do the results mean?

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties